We are live on ! Find out more
PCM

Peregrine Capital Management Portfolio holdings

AUM $3.08B
1-Year Est. Return 29.51%
This Fund
S&P 500
This Quarter Est. Return
+8.84%
1 Year Est. Return
+29.51%
3 Year Est. Return
+95.04%
5 Year Est. Return
+107.83%
10 Year Est. Return
+715.34%
AUM
$3.19B
AUM Growth
+$101M
Cap. Flow
-$58.6M
Cap. Flow %
-1.84%
Top 10 Hldgs %
16.65%
Holding
340
New
17
Increased
56
Reduced
185
Closed
23

Top Buys

Rank Stock Value
1
SNOW icon
Snowflake
SNOW
+$27.5M
2
UBER icon
Uber
UBER
+$20.6M
3
GDEN
Golden Entertainment
GDEN
+$10.5M
4
THS
Treehouse Foods
THS
+$10.1M
5
HBI
Hanesbrands
HBI
+$9.58M

Top Sells

Rank Stock Value
1
ABMD
Abiomed Inc
ABMD
+$29.4M
2
AVLR
Avalara, Inc.
AVLR
+$29.4M
3
EVOP
EVO Payments, Inc. Class A Common Stock
EVOP
+$14.3M
4
META icon
Meta Platforms (Facebook)
META
+$12.9M
5
SYNH
Syneos Health, Inc. Class A Common Stock
SYNH
+$12.9M

Sector Composition

Rank Sector Weight
1 Technology 20.39%
2 Healthcare 18.05%
3 Financials 16.4%
4 Consumer Discretionary 13.46%
5 Industrials 11.67%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
VICR icon
201
Vicor
VICR
$9.72B
$7.36M 0.23%
136,991
-4,153
-3% -$218K
CYTK icon
202
Cytokinetics
CYTK
$10.6B
$7.34M 0.23%
160,143
+11,309
+8% +$487K
VRNS icon
203
Varonis Systems
VRNS
$4.84B
$7.34M 0.23%
+306,474
New +$7M
SRI icon
204
Stoneridge
SRI
$193M
$7.33M 0.23%
340,083
-3,681
-1% -$78.8K
ZWS icon
205
Zurn Elkay Water Solutions
ZWS
$8.6B
$7.33M 0.23%
346,530
-10,482
-3% -$247K
VIRT icon
206
Virtu Financial
VIRT
$4.86B
$7.06M 0.22%
345,885
-10,250
-3% -$223K
DV icon
207
DoubleVerify
DV
$2.03B
$7.04M 0.22%
320,363
-9,680
-3% -$252K
INSM icon
208
Insmed
INSM
$29B
$7.01M 0.22%
350,969
-10,634
-3% -$206K
PLMR icon
209
Palomar
PLMR
$3.47B
$6.99M 0.22%
154,834
-4,758
-3% -$324K
APPS icon
210
Digital Turbine
APPS
$1.58B
$6.96M 0.22%
456,946
-148,944
-25% -$2.29M
ATRC icon
211
AtriCure
ATRC
$2.18B
$6.96M 0.22%
156,863
-50,361
-24% -$2.1M
DK icon
212
Delek US
DK
$3.92B
$6.92M 0.22%
256,470
-2,777
-1% -$82K
PCRX icon
213
Pacira BioSciences
PCRX
$972M
$6.92M 0.22%
179,174
+28,712
+19% +$1.4M
SYNA icon
214
Synaptics
SYNA
$4.18B
$6.88M 0.22%
72,283
-2,174
-3% -$209K
RAMP icon
215
LiveRamp
RAMP
$2.3B
$6.88M 0.22%
293,326
-7,351
-2% -$148K
USPH icon
216
US Physical Therapy
USPH
$1.22B
$6.86M 0.22%
84,705
-2,511
-3% -$211K
AZTA icon
217
Azenta
AZTA
$1.54B
$6.75M 0.21%
115,901
-3,521
-3% -$180K
RARE icon
218
Ultragenyx Pharmaceutical
RARE
$2.66B
$6.69M 0.21%
144,306
+25,377
+21% +$998K
IAA
219
DELISTED
IAA, Inc. Common Stock
IAA
$6.32M 0.2%
158,042
-4,937
-3% -$186K
SONO icon
220
Sonos
SONO
$1.78B
$6.31M 0.2%
373,506
-11,287
-3% -$184K
PRVA icon
221
Privia Health
PRVA
$2.81B
$6.23M 0.2%
274,467
+63,942
+30% +$1.78M
DOLE icon
222
Dole
DOLE
$1.23B
$6.21M 0.19%
643,971
-6,967
-1% -$63.4K
MLKN icon
223
MillerKnoll
MLKN
$1.62B
$5.8M 0.18%
275,934
-3,005
-1% -$60.1K
UEIC icon
224
Universal Electronics
UEIC
$74.6M
$5.79M 0.18%
278,013
-3,015
-1% -$62.5K
BPMC
225
DELISTED
Blueprint Medicines
BPMC
$5.62M 0.18%
128,242
+15,954
+14% +$765K
7 8
9
10 11

Similar funds

CAM
Contour Asset Management New York $3.08B AUM 21.94% 1-Year Est. Return
MRCP
Maple Rock Capital Partners Toronto, Ontario, Canada $3.07B AUM 157.2% 1-Year Est. Return
ECP
Empyrean Capital Partners Los Angeles, California $3.07B AUM 34.24% 1-Year Est. Return
HCM
Highbridge Capital Management New York $3.09B AUM 31.21% 1-Year Est. Return
TCG
Tremblant Capital Group West Palm Beach, Florida $3.11B AUM 18.12% 1-Year Est. Return
CLG
Cooperman Leon G $3.05B AUM 42.78% 1-Year Est. Return
SAG
Susquehanna Advisors Group Bala Cynwyd, Pennsylvania $3.05B AUM 41.49% 1-Year Est. Return
PC
Paulson & Co New York $3.11B AUM 94.93% 1-Year Est. Return

Peregrine Capital Management's Q4 2022 Portfolio in Review

As of Q4 2022, Peregrine Capital Management held 340 positions worth $3.19B, up 3.3% from $3.09B the previous quarter. Its ten largest holdings account for 17% of the portfolio.

Peregrine Capital Management's Q4 2022 filing shows 17 new, 56 increased, 185 reduced and 23 closed positions. Its largest new stake was Snowflake: 180,455 shares worth $25.9M. The largest sale was Abiomed Inc, an estimated $29.4M.

By sector, the portfolio is most concentrated in Technology at 20% of assets, up from 20% a quarter earlier, followed by Healthcare and Financials.

  • Peregrine Capital Management's largest Q4 2022 buy was Snowflake: 180,455 shares worth $25.9M.
  • Peregrine Capital Management added most to CrowdStrike in Q4 2022, an estimated $7.47M increase.
  • Peregrine Capital Management's biggest Q4 2022 reduction was EVO Payments, Inc. Class A Common Stock, cutting an estimated $14.3M.
  • Peregrine Capital Management fully exited Abiomed Inc in Q4 2022, selling an estimated $29.4M.
  • Peregrine Capital Management's ten largest holdings make up 17% of its $3.19B portfolio in Q4 2022.
  • Peregrine Capital Management opened 17 new positions and closed 23 in Q4 2022.
  • Peregrine Capital Management's portfolio value rose 3.3% quarter-over-quarter to $3.19B.

Based on Peregrine Capital Management's 13F filing for Q4 2022, filed 10 Jan 2023.